Richard E Banks1, Brigid M Wilson1,2, Taissa Bej1, Janet M Briggs1, Sunah Song3,4, Michihiko Goto5,6, Robin L P Jump1,2,4, Federico Perez1,2. 1. Geriatric Research Education and Clinical Center, Veterans Affairs Northeast Ohio Healthcare System, Cleveland, Ohio, USA. 2. Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. 3. Cleveland Institute for Computational Biology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. 4. Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. 5. Center for Comprehensive Access and Delivery Research and Evaluation, Iowa City Veterans Affairs Healthcare System, Iowa City, Iowa, USA. 6. Department of Internal Medicine, Division of Infectious Diseases, University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City, Iowa, USA.
Abstract
BACKGROUND: The nosology of noninvasive pneumonia due to group B Streptococcus (GBS) is not well defined. This study compared clinical characteristics and outcomes of patients with invasive pneumonia and noninvasive pneumonia caused by GBS. METHODS: We conducted a retrospective cohort study among Veterans Affairs (VA) healthcare users between 2008 and 2017. Using data from electronic health records, we identified patients who had blood or respiratory cultures that grew GBS and had invasive pneumonia or noninvasive pneumonia. We analyzed patient and infection characteristics associated with all-cause mortality, including among the subset of patients with cultures that were monomicrobial for GBS. RESULTS: Among 1791 patients with GBS pneumonia, 646 (36%) cases were invasive and 1145 (64%) were noninvasive. Among those, 535 and 424 cases of invasive and noninvasive pneumonia, respectively, had cultures that were monomicrobial for GBS. All-cause 30-day mortality among those with monomicrobial GBS pneumonia was 15% for both those with invasive and noninvasive disease, respectively. Increasing age, severity of illness, healthcare exposure in the previous 90 days, and polymicrobial infection with Staphylococcus aureus were independently associated with all-cause mortality at 30 days. CONCLUSIONS: In this large cohort, even when considering cases for which GBS was the only pathogen recovered, >40% of GBS pneumonia cases were noninvasive. All-cause mortality was comparable for invasive and noninvasive pneumonia. These findings suggest that the burden of GBS pneumonia may be greater than previously recognized by surveillance of invasive GBS disease and may inform treatment and prevention efforts. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2022.
BACKGROUND: The nosology of noninvasive pneumonia due to group B Streptococcus (GBS) is not well defined. This study compared clinical characteristics and outcomes of patients with invasive pneumonia and noninvasive pneumonia caused by GBS. METHODS: We conducted a retrospective cohort study among Veterans Affairs (VA) healthcare users between 2008 and 2017. Using data from electronic health records, we identified patients who had blood or respiratory cultures that grew GBS and had invasive pneumonia or noninvasive pneumonia. We analyzed patient and infection characteristics associated with all-cause mortality, including among the subset of patients with cultures that were monomicrobial for GBS. RESULTS: Among 1791 patients with GBS pneumonia, 646 (36%) cases were invasive and 1145 (64%) were noninvasive. Among those, 535 and 424 cases of invasive and noninvasive pneumonia, respectively, had cultures that were monomicrobial for GBS. All-cause 30-day mortality among those with monomicrobial GBS pneumonia was 15% for both those with invasive and noninvasive disease, respectively. Increasing age, severity of illness, healthcare exposure in the previous 90 days, and polymicrobial infection with Staphylococcus aureus were independently associated with all-cause mortality at 30 days. CONCLUSIONS: In this large cohort, even when considering cases for which GBS was the only pathogen recovered, >40% of GBS pneumonia cases were noninvasive. All-cause mortality was comparable for invasive and noninvasive pneumonia. These findings suggest that the burden of GBS pneumonia may be greater than previously recognized by surveillance of invasive GBS disease and may inform treatment and prevention efforts. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2022.
Authors: Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali Journal: Med Care Date: 2005-11 Impact factor: 2.983
Authors: Spyridon Fortis; Amy M J O'Shea; Brice F Beck; Rajeshwari Nair; Michihiko Goto; Peter J Kaboli; Eli N Perencevich; Heather S Reisinger; Mary V Sarrazin Journal: J Crit Care Date: 2018-09-06 Impact factor: 3.425
Authors: Sarah Haessler; Peter K Lindenauer; Marya D Zilberberg; Peter B Imrey; Pei-Chun Yu; Tom Higgins; Abhishek Deshpande; Michael B Rothberg Journal: Clin Infect Dis Date: 2020-10-23 Impact factor: 9.079
Authors: Samantha I Pitts; Nisa M Maruthur; Gayle E Langley; Tracy Pondo; Kathleen A Shutt; Rosemary Hollick; Stephanie J Schrag; Ann Thomas; Megin Nichols; Monica Farley; James P Watt; Lisa Miller; William Schaffner; Corinne Holtzman; Lee H Harrison Journal: Open Forum Infect Dis Date: 2018-06-08 Impact factor: 3.835
Authors: Niyati M Gupta; Peter K Lindenauer; Pei-Chun Yu; Peter B Imrey; Sarah Haessler; Abhishek Deshpande; Thomas L Higgins; Michael B Rothberg Journal: JAMA Netw Open Date: 2019-06-05
Authors: Robin L P Jump; Brigid M Wilson; Daniel Baechle; Janet M Briggs; Richard E Banks; Sunah Song; Taissa Zappernick; Federico Perez Journal: JAMA Netw Open Date: 2019-12-02